Helping women with a history of gestational diabetes prevent type 2 diabetes.
A Shared Decision Making Intervention for Diabetes Prevention in Women with a History of Gestational Diabetes Mellitus.
This study is helping women who had gestational diabetes learn about their options for preventing type 2 diabetes, using a friendly tool that makes it easier for them to choose the best path for their health and lifestyle.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10992133 on NIH RePORTER |
What this research studies
This research focuses on women who have had gestational diabetes mellitus (GDM) and are at high risk for developing type 2 diabetes. It employs a shared decision-making approach, where patients are provided with a decision aid to help them understand their options for diabetes prevention, including lifestyle changes and medication. The goal is to empower these women to make informed choices that align with their preferences and health goals. The study will evaluate the effectiveness and acceptability of this approach in two health systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have experienced gestational diabetes and are at risk for developing type 2 diabetes.
Not a fit: Patients who have not had gestational diabetes or those who already have type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of type 2 diabetes in women with a history of gestational diabetes.
How similar studies have performed: Previous studies have shown success with shared decision-making approaches in diabetes prevention, indicating potential for this method to be effective in this specific population.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Duru, Obidiugwu Kenrik — University of California Los Angeles
- Study coordinator: Duru, Obidiugwu Kenrik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.